Induction of the autonomous stage of transformation in erythroid cells infected with SFFV: helper virus is not required.
The erythroleukemia induced by the Friend spleen focus-forming virus (SFFV) in mice exemplifies a multistep oncogenic process. Its sequential steps include a rapid polyclonal hyperplastic stage and a more slowly developing malignant stage characterized by autonomous erythroid cells. We report here that the helper virus normally present in mice infected by SFFV is not required for development of the second stage of transformation. In this study, mice were infected with a polycythemia-inducing variant of SFFV which was prepared as a helper-free stock (L. Wolff and S. Ruscetti, 1985, Science 228, 1549). Highly malignant cells could be detected in helper-free SFFV-infected mice by their transplantability into the omentum of sublethally irradiated mice, and erythroleukemia cell lines, typical of previously isolated Friend murine erythroleukemia cell lines, could be established from diseased spleens. Like their helper virus-containing counterparts, the lines established with helper-free SFFV are inducible for hemoglobin synthesis with a variety of chemicals, but not erythropoietin, and express p53, a marker of malignant transformation. Although the cells expressed SFFV encoded proteins, none expressed gene products of replication competent murine leukemia viruses.
D000818:Animals; D002472:Cell Transformation, Viral; D005622:Friend murine leukemia virus; D006378:Helper Viruses / Q000502:physiology; D009052:Leukemia Virus, Murine / Q000502:physiology*; D004915:Leukemia, Erythroblastic, Acute / Q000382:microbiology*; D051379:Mice; D008815:Mice, Inbred Strains; D013154:Spleen / Q000382:microbiology; D013155:Spleen Focus-Forming Viruses / Q000502:physiology*; D014759:Viral Envelope Proteins / Q000378:metabolism
D014759:Viral Envelope Proteins